Abstract
Erratum : Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis
Full Text
Topics from this Paper
Activation Of Hepatic Stellate Cells
Mouse Liver Fibrosis
Activation Of Stellate Cells
Activation Of Cells
Hepatic Stellate Cells
+ Show 4 more
Create a personalized feed of these topics
Get StartedTalk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis 
Relevant
Not Relevant
Gastroenterology
Jan 1, 2008
Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway 
Relevant
Not Relevant
European Journal of Pharmacology
May 1, 2021
MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice 
Relevant
Not Relevant
Molecular Therapy
Oct 1, 2016
Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR. 
Relevant
Not Relevant
Phytomedicine : international journal of phytotherapy and phytopharmacology
Dec 1, 2022
Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution 
Relevant
Not Relevant
Gastroenterology
May 1, 2020
Mechanism of Ulcerative Colitis-Aggravated Liver Fibrosis: The Activation of Hepatic Stellate Cells and TLR4 Signaling Through Gut-Liver Axis 
Relevant
Not Relevant
Frontiers in Physiology
Sep 17, 2021
Role of Fibroblast Growth Factor Type 1 and 2 in Carbon Tetrachloride-Induced Hepatic Injury and Fibrogenesis 
Relevant
Not Relevant
The American Journal of Pathology
Oct 1, 2003
Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies 
Relevant
Not Relevant
Clinical Gastroenterology and Hepatology
Mar 1, 2013
Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis 
Relevant
Not Relevant
Human Cell
May 24, 2020
Autophagy and hepatic stellate cell activation – Partners in crime? 
Relevant
Not Relevant
Journal of Hepatology
Dec 1, 2011
NAMPT-mediated NAD+ biosynthesis suppresses activation of hepatic stellate cells and protects against CCl4-induced liver fibrosis in mice 
Relevant
Not Relevant
Human & Experimental Toxicology
Nov 9, 2021
Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation 
Relevant
Not Relevant
Cellular Physiology and Biochemistry
Jul 13, 2018
Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice 
Relevant
Not Relevant
Journal of Hepatology
Jan 1, 2016
The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation 
Relevant
Not Relevant
Biomedicine & Pharmacotherapy
Oct 1, 2018
CaM/CaMKII mediates activation and proliferation of hepatic stellate cells regulated by ASIC1a 
Relevant
Not Relevant
Frontiers in Pharmacology
Dec 15, 2022
Hepatology
Erratum: KIAA1199 drives immune suppression to promote colorectal cancer liver metastasis by modulating neutrophil infiltration
Open Access
Relevant
Not Relevant
Hepatology
Nov 17, 2023
Erratum: Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis
Open Access
Relevant
Not Relevant
Hepatology
Nov 17, 2023
Erratum: Diabetes and cirrhosis: Current concepts on diagnosis and management
Open Access
Relevant
Not Relevant
Hepatology
Nov 17, 2023
Erratum: Activation of pregnane X receptor sensitizes mice to hemorrhagic shock induced liver injury journal
Open Access
Relevant
Not Relevant
Hepatology
Nov 17, 2023
Benefit and harm of waiting time in liver transplantation for HCC 
Relevant
Not Relevant
Hepatology
Nov 16, 2023
A Public health perspective on mitigating the global burden of chronic liver disease 
Relevant
Not Relevant
Hepatology
Nov 9, 2023
MicroRNA-206-3p suppresses hepatic lipogenesis and cholesterol synthesis while driving cholesterol efflux 
Relevant
Not Relevant
Hepatology
Nov 9, 2023
AASLD Practice guidance on Acute-on-chronic liver failure and the management of critically Ill patients with cirrhosis 
Relevant
Not Relevant
Hepatology
Nov 9, 2023
Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals 
Relevant
Not Relevant
Hepatology
Nov 9, 2023